TITLE

ONSET AND CLINICOPATHOLOGICAL COURSE IN BUERGER'S DISEASE

AUTHOR(S)
Nakata, Yukifumi; Ban, Ichiro; Hirai, Masafumi; Shionoya, Shigehiko
PUB. DATE
September 1976
SOURCE
Angiology;Sep1976, Vol. 27 Issue 9, p509
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
From clinicopathological study, vasculitis of Buerger's disease seemed to start at small branch arteries and veins and progress to the trunk artery with thrombus, Progress of vascular lesions in trunk artery was gradual in general; the pathogenesis was briefly discussed.
ACCESSION #
16352494

 

Related Articles

  • NEW CLINICAL APPROACH TO THE MANAGEMENT OF INTERMITTENT CLAUDICATION (ANGINA CRURIS). Samuels, Saul S.; Shaftel, Herbert E. // Angiology;Dec1958, Vol. 9 Issue 6, p378 

    Examines a clinical approach to the management of intermittent claudication or angina cruris. Consideration of plethysmographic studies in judging the effect of vasodilating drugs on the peripheral circulation; Importance of supplementing vasodilators with tranquilizers; Description of the...

  • ALTERATIONS IN COLLAGEN IN THE ARTERIES OF THROMBOANGIITIC PATIENTS. Peracchia, C.; Vassallo, C. // Angiology;Jul1966, Vol. 17 Issue 7, p451 

    Electron microscopy has revealed marked and typical modifications of collagen in the part of the artery affected by Buerger's disease. Thickening of the fibrils due to dissociation of the subfilaments and their fragmentation and disintegration into an amorphous substance are described. The close...

  • A Botanical Compound, Padma 28, Increases Walking Distance in Stable Intermittent Claudication. Drabaek, Hans; Mehlsen, Jesper; Himmelstrup, Holger; Winther, Kaj // Angiology;Nov1993, Vol. 44 Issue 11, p863 

    Thirty-six patients with a median age of sixty-seven years and a median duration of intermittent claudication of five years were randomized to either active treatment with Padma 28 or placebo. The effect of treatment was quantified by measurements of systemic and peripheral systolic blood...

  • Efficacy and Safety of Pentoxifylline in Geriatric Patients with Intermittent Claudication. Crowder, John E.; Cohn, Jay B.; Savitsky, J. Philip; Morgan, DeAnn L.; Slywka, Joseph; Cobert, Barton L.; Hryniewicki, Stephen W.; Piccirillo, Ronald T.; Wilcox, Charles S. // Angiology;Sep1989, Vol. 40 Issue 9, p795 

    The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD). Standardized treadmill testing and clinical signs and symptoms of COAD were followed up...

  • Update on Thromboangiitis Obliterans (Buerger's Disease). Kirchner, Jeffrey T. // American Family Physician;3/15/2001, Vol. 63 Issue 6, p1195 

    Presents a study by J.W. Olin on the current concepts of thromboangiitis obliterans, also known as Buerger's disease. Description of the study and its results; Effective treatment methods.

  • New developments in intermittent claudication. Stansby, Gerard // Pulse;4/30/2005, Vol. 65 Issue 17, p57 

    The article cites new developments in intermittent claudication (IC). Background IC is often the first symptom of peripheral arterial disease and is usually due to widespread atherosclerosis. However, IC symptoms often go unreported by patients since they assume the cramp-like pain on walking to...

  • The low down on claudicant leg pain. Targett, Steve // New Zealand Doctor;6/14/2006, p34 

    Presents information on claudicant leg pain. Description of the leg pain; Causes; Treatment.

  • A TWO-STEP TEST OF EXERCISE TOLERANCE IN INTERMITTENT CLAUDICATION. Kissin, Milton; Steix, Julius J.; Adleman, Ralph J. // Angiology;Apr1950, Vol. 1 Issue 2, p141 

    A two-step stair climbing test was found to be a satisfactory and convenient measure of exercise tolerance in intermittent claudication. The patient walked back and forth over a set of steps until pain appeared in the leg. The number of trips made over the steps was recorded as the exercise...

  • The prognostic impact of general and abdominal obesity in peripheral arterial disease. Giugliano, G.; Brevetti, G.; Laurenzano, E.; Brevetti, L.; Luciano, R.; Chiariello, M. // International Journal of Obesity;Feb2010, Vol. 34 Issue 2, p280 

    Objective:Obesity is an independent cardiovascular risk factor, but its prognostic role in patients with peripheral arterial disease (PAD) is not well defined. Accordingly, we assessed the impact of body mass index (BMI) and waist circumference (WC) on cardiovascular risk in a homogeneous cohort...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics